Propranolol Dosing for Thyroid Storm
For thyroid storm, initiate propranolol at 40-80 mg orally every 6-8 hours (total daily dose 160-320 mg), or for intravenous administration in critically ill patients, use 0.5-1 mg IV slowly over 10 minutes, repeated as needed. 1, 2
Initial Dosing Strategy
- Oral propranolol: Start with 40-80 mg every 6-8 hours, with typical total daily doses ranging from 160-320 mg divided throughout the day 3, 2
- Intravenous propranolol: For patients unable to take oral medications or in severe thyroid storm, administer 0.5-1 mg IV slowly, which can be repeated as clinically indicated 1
- The average effective dose in surgical series was 160 mg/day, with a range of 40-320 mg/day depending on symptom control 3
Critical Pre-Treatment Assessment
Before administering propranolol in thyroid storm, you must exclude absolute contraindications that could precipitate cardiovascular collapse:
- Assess for heart failure: Examine for signs of low cardiac output, decompensated heart failure, or significantly reduced ejection fraction 4, 5
- Check for heart block: Second or third-degree AV block is an absolute contraindication 1, 6
- Evaluate respiratory status: Active asthma or severe obstructive airway disease precludes propranolol use 1, 2
- Measure baseline vital signs: Document heart rate and blood pressure before initiating therapy 6
Critical Safety Warning: Risk of Cardiovascular Collapse
Propranolol can precipitate sudden cardiovascular collapse in thyroid storm patients with underlying cardiac dysfunction, particularly those with low output heart failure or severely reduced ejection fraction. 4, 5
- Three documented cases showed asystolic cardiorespiratory arrest occurring 6-12 hours after oral propranolol administration in thyroid storm patients 5
- One case demonstrated cardiovascular collapse immediately after propranolol in a patient with ejection fraction of 10% 4
- In patients with suspected or confirmed heart failure complicating thyroid storm, consider ultra-short-acting IV esmolol instead of propranolol, as it allows rapid titration and discontinuation if adverse effects occur 5
Alternative Beta-Blocker Considerations
- Beta-1 selective agents (e.g., esmolol, metoprolol) are equally effective as propranolol for thyroid storm and may be safer in patients with borderline cardiac function 7
- A large retrospective study of 2,462 patients found no difference in in-hospital mortality between beta-1 selective blockers and propranolol (6.3% vs 7.4%), even in patients with acute heart failure 7
- Japanese guidelines now recommend beta-1 selective agents over propranolol, though evidence is limited 7
Monitoring During Treatment
- Monitor heart rate and blood pressure closely, especially in the first 24 hours after initiation 6
- Watch for signs of worsening heart failure: increased dyspnea, hypotension, or bradycardia 6
- Continue propranolol until clinical remission of thyrotoxic symptoms (tachycardia, tremor, fever, agitation) 2
- Do not abruptly discontinue propranolol after chronic use; taper gradually to prevent rebound tachycardia 6
Adjunctive Therapy Context
- Propranolol should always be combined with antithyroid drugs (propylthiouracil or methimazole), corticosteroids, and treatment of the precipitating cause 1
- Propranolol has the additional benefit of inhibiting peripheral conversion of T4 to T3, making it theoretically superior to other beta-blockers, though clinical outcomes are equivalent 7
- Iodine administration (potassium iodide or Lugol's solution) should follow antithyroid drugs by at least 1 hour 1